Your browser doesn't support javascript.
loading
Differential levels of IFNα subtypes in autoimmunity and viral infection.
Bondet, Vincent; Rodero, Mathieu P; Posseme, Céline; Bost, Pierre; Decalf, Jérémie; Haljasmägi, Liis; Bekaddour, Nassima; Rice, Gillian I; Upasani, Vinit; Herbeuval, Jean-Philippe; Reynolds, John A; Briggs, Tracy A; Bruce, Ian N; Mauri, Claudia; Isenberg, David; Menon, Madhvi; Hunt, David; Schwikowski, Benno; Mariette, Xavier; Pol, Stanislas; Rozenberg, Flore; Cantaert, Tineke; Eric Gottenberg, J; Kisand, Kai; Duffy, Darragh.
Afiliação
  • Bondet V; Translational Immunology Lab, Institut Pasteur, Paris, France.
  • Rodero MP; Chimie & Biologie, Modélisation et Immunologie pour la Thérapie (CBMIT), Université de Paris, CNRS, UMR8601, Paris, France.
  • Posseme C; Translational Immunology Lab, Institut Pasteur, Paris, France; Frontiers of Innovation in Research and Education PhD program, CRI doctoral school, Université de Paris, Paris 75005, France.
  • Bost P; Systems Biology Group, Department of Computational Biology and USR 3756, Institut Pasteur and CNRS, Paris 75015, France; Sorbonne Universite, Complexite du vivant, Paris 75005, France.
  • Decalf J; Translational Immunology Lab, Institut Pasteur, Paris, France.
  • Haljasmägi L; Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
  • Bekaddour N; Chimie & Biologie, Modélisation et Immunologie pour la Thérapie (CBMIT), Université de Paris, CNRS, UMR8601, Paris, France.
  • Rice GI; Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Upasani V; Immunology Unit, Institut Pasteur du Cambodge, Institut Pasteur International Network, Phnom Penh, Cambodia.
  • Herbeuval JP; Chimie & Biologie, Modélisation et Immunologie pour la Thérapie (CBMIT), Université de Paris, CNRS, UMR8601, Paris, France.
  • Reynolds JA; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Th
  • Briggs TA; Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Bruce IN; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Th
  • Mauri C; Centre for Rheumatology Research, Division of Medicine, University College of London, London WC1E 6JF, UK.
  • Isenberg D; Centre for Rheumatology Research, Division of Medicine, University College of London, London WC1E 6JF, UK.
  • Menon M; Centre for Rheumatology Research, Division of Medicine, University College of London, London WC1E 6JF, UK; Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity & Respiratory Medicine, School of Biological Sciences, University of Manchester, UK.
  • Hunt D; Centre for Genomic and Experimental Medicine, Medical Research Council Institute of Genetics and Molecular Medicine, The University of Edinburgh, Edinburgh, UK.
  • Schwikowski B; Systems Biology Group, Department of Computational Biology and USR 3756, Institut Pasteur and CNRS, Paris 75015, France; Sorbonne Universite, Complexite du vivant, Paris 75005, France.
  • Mariette X; Rheumatology, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre, INSERM UMR1184, Le Kremlin-Bicetre, France.
  • Pol S; Unite d'Hépatologie, Assistance Publique-Hopitaux de Paris (AP-HP), Hopital Cochin, Paris, France.
  • Rozenberg F; Department of Virology, APHP-CUP, Université de Paris, Paris, France.
  • Cantaert T; Immunology Unit, Institut Pasteur du Cambodge, Institut Pasteur International Network, Phnom Penh, Cambodia.
  • Eric Gottenberg J; Faculté de Médecine de l'Université de Strasbourg, Strasbourg, France.
  • Kisand K; Molecular Pathology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia.
  • Duffy D; Translational Immunology Lab, Institut Pasteur, Paris, France. Electronic address: darragh.duffy@pasteur.fr.
Cytokine ; 144: 155533, 2021 08.
Article em En | MEDLINE | ID: mdl-33941444
ABSTRACT
Type I interferons are essential for host response to viral infections, while dysregulation of their response can result in autoinflammation or autoimmunity. Among IFNα (alpha) responses, 13 subtypes exist that signal through the same receptor, but have been reported to have different effector functions. However, the lack of available tools for discriminating these closely related subtypes, in particular at the protein level, has restricted the study of their differential roles in disease. We developed a digital ELISA with specificity and high sensitivity for the IFNα2 subtype. Application of this assay, in parallel with our previously described pan-IFNα assay, allowed us to study different IFNα protein responses following cellular stimulation and in diverse patient cohorts. We observed different ratios of IFNα protein responses between viral infection and autoimmune patients. This analysis also revealed a small percentage of autoimmune patients with high IFNα2 protein measurements but low pan-IFNα measurements. Correlation with an ISG score and functional activity showed that in this small sub group of patients, IFNα2 protein measurements did not reflect its biological activity. This unusual phenotype was partly explained by the presence of anti-IFNα auto-antibodies in a subset of autoimmune patients. This study reports ultrasensitive assays for the study of IFNα proteins in patient samples and highlights the insights that can be obtained from the use of multiple phenotypic readouts in translational and clinical studies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Viroses / Autoimunidade / Interferon-alfa Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Cytokine Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Viroses / Autoimunidade / Interferon-alfa Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Revista: Cytokine Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França